1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > United States Medicine in Prostate Cancer Industry 2015 Market Research Report

Summary


The United States Medicine in Prostate Cancer Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Medicine in Prostate Cancer industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Medicine in Prostate Cancer market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Medicine in Prostate Cancer industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 146 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

United States Medicine in Prostate Cancer Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Medicine in Prostate Cancer
1.2 Classification of Medicine in Prostate Cancer
1.3 Applications of Medicine in Prostate Cancer
1.4 Industry Chain Structure of Medicine in Prostate Cancer
1.5 Industry Overview of Medicine in Prostate Cancer
1.6 Industry Policy Analysis of Medicine in Prostate Cancer
1.7 Industry News Analysis of Medicine in Prostate Cancer

2 Manufacturing Cost Structure Analysis of Medicine in Prostate Cancer
2.1 Bill of Materials (BOM) of Medicine in Prostate Cancer
2.2 BOM Price Analysis of Medicine in Prostate Cancer
2.3 Labor Cost Analysis of Medicine in Prostate Cancer
2.4 Depreciation Cost Analysis of Medicine in Prostate Cancer
2.5 Manufacturing Cost Structure Analysis of Medicine in Prostate Cancer
2.6 Manufacturing Process Analysis of Medicine in Prostate Cancer
2.7 China Price, Cost and Gross of Medicine in Prostate Cancer 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Medicine in Prostate Cancer Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Medicine in Prostate Cancer Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Medicine in Prostate Cancer Key Manufacturers in 2014

4 Production Analysis of Medicine in Prostate Cancer by Regions, Type, and Applications
4.1 United States Production of Medicine in Prostate Cancer by Regions 2010-2015
4.2 United States Production of Medicine in Prostate Cancer by Type 2010-2015
4.3 United States Sales of Medicine in Prostate Cancer by Applications 2010-2015
4.4 Price Analysis of United States Medicine in Prostate Cancer Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Medicine in Prostate Cancer 2010-2015

5 Consumption Volume and Consumption Value Analysis of Medicine in Prostate Cancer by Regions
5.1 United States Consumption Volume of Medicine in Prostate Cancer by Regions 2010-2015
5.2 United States Consumption Value of Medicine in Prostate Cancer by Regions 2010-2015
5.3 United States Consumption Price Analysis of Medicine in Prostate Cancer by Regions 2010-2015

6 Analysis of Medicine in Prostate Cancer Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Medicine in Prostate Cancer 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Medicine in Prostate Cancer 2014-2015
6.3 Sales Overview of Medicine in Prostate Cancer 2010-2015
6.4 Supply, Consumption and Gap of Medicine in Prostate Cancer 2010-2015
6.5 Import, Export and Consumption of Medicine in Prostate Cancer 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Medicine in Prostate Cancer 2010-2015

7 Analysis of Medicine in Prostate Cancer Industry Key Manufacturers
7.1 Abbott Diagnostics
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Abbott Diagnostics SWOT Analysis

7.2 Active Biotech
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Active Biotech SWOT Analysis

7.3 Advantagene
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Advantagene SWOT Analysis

7.4 AEterna Zentaris
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 AEterna Zentaris SWOT Analysis

7.5 Alchemia
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Alchemia SWOT Analysis

7.6 Alethia Biotherapeutics
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Alethia Biotherapeutics SWOT Analysis

7.7 Generex
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Generex SWOT Analysis

7.8 Alseres
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Alseres SWOT Analysis

7.9 Bayer
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 Bayer SWOT Analysis

7.10 Altor BioScience
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Altor BioScience SWOT Analysis

7.11 Bavarian Nordic
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Bavarian Nordic SWOT Analysis

7.12 Amgen
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Amgen SWOT Analysis

7.13 Inovio
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Inovio SWOT Analysis

7.14 Anavex
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Anavex SWOT Analysis

7.15 Antisense Pharma
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 Antisense Pharma SWOT Analysis

7.16 Aphios
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Aphios SWOT Analysis

7.17 Apotex
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Apotex SWOT Analysis

7.18 Aprea
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 Aprea SWOT Analysis

7.19 MediGene
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 MediGene SWOT Analysis

7.20 Array BioPharma
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 Array BioPharma SWOT Analysis

7.21 Bioenvision
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Bioenvision SWOT Analysis

7.22 Astellas
7.22.1 Company Profile
7.22.2 Product Picture and Specification
7.22.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.22.4 Astellas SWOT Analysis

7.23 Astex
7.23.1 Company Profile
7.23.2 Product Picture and Specification
7.23.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.23.4 Astex SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Medicine in Prostate Cancer Product Types
8.5 Market Share Analysis of Different Medicine in Prostate Cancer Price Levels
8.6 Gross Margin Analysis of Different Medicine in Prostate Cancer Applications

9 Marketing Trader or Distributor Analysis of Medicine in Prostate Cancer
9.1 Marketing Channels Status of Medicine in Prostate Cancer
9.2 Traders or Distributors of Medicine in Prostate Cancer with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Medicine in Prostate Cancer
9.4 United States Import, Export and Trade Analysis of Medicine in Prostate Cancer

10 Development Trend of Medicine in Prostate Cancer Industry 2016-2021
10.1 Capacity and Production Overview of Medicine in Prostate Cancer 2016-2021
10.2 Production Market Share by Product Types of Medicine in Prostate Cancer 2016-2021
10.3 Sales and Sales Revenue Overview of Medicine in Prostate Cancer 2016-2021
10.4 United States Sales of Medicine in Prostate Cancer by Applications 2016-2021
10.5 Import, Export and Consumption of Medicine in Prostate Cancer 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Medicine in Prostate Cancer 2016-2021

11 Industry Chain Suppliers of Medicine in Prostate Cancer with Contact Information
11.1 Major Raw Materials Suppliers of Medicine in Prostate Cancer with Contact Information
11.2 Manufacturing Equipment Suppliers of Medicine in Prostate Cancer with Contact Information
11.3 Major Players of Medicine in Prostate Cancer with Contact Information
11.4 Key Consumers of Medicine in Prostate Cancer with Contact Information
11.5 Supply Chain Relationship Analysis of Medicine in Prostate Cancer

12 New Project Investment Feasibility Analysis of Medicine in Prostate Cancer
12.1 New Project SWOT Analysis of Medicine in Prostate Cancer
12.2 New Project Investment Feasibility Analysis of Medicine in Prostate Cancer

13 Conclusion of the United States Medicine in Prostate Cancer Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Medicine in Prostate Cancer
Table Product Specifications of Medicine in Prostate Cancer
Table Classification of Medicine in Prostate Cancer
Figure United States Sales Market Share of Medicine in Prostate Cancer by Product Types in 2014
Table Applications of Medicine in Prostate Cancer
Figure United States Sales Market Share of Medicine in Prostate Cancer by Applications in 2014
Figure Industry Chain Structure of Medicine in Prostate Cancer
Table United States Industry Overview of Medicine in Prostate Cancer
Table Industry Policy of Medicine in Prostate Cancer
Table Industry News List of Medicine in Prostate Cancer
Table Bill of Materials (BOM) of Medicine in Prostate Cancer
Table Bill of Materials (BOM) Price of Medicine in Prostate Cancer
Table Labor Cost of Medicine in Prostate Cancer
Table Depreciation Cost of Medicine in Prostate Cancer
Table Manufacturing Cost Structure Analysis of Medicine in Prostate Cancer in 2014
Figure Manufacturing Process Analysis of Medicine in Prostate Cancer
Table United States Price Analysis of Medicine in Prostate Cancer 2010-2015 (USD/Dose)
Table United States Cost Analysis of Medicine in Prostate Cancer 2010-2015 (USD/Dose)
Table United States Gross Analysis of Medicine in Prostate Cancer 2010-2015
Table Capacity (Dose) and Commercial Production Date of United States Medicine in Prostate Cancer Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Medicine in Prostate Cancer Manufacturers in 2014
Table RandD Status and Technology Source of United States Medicine in Prostate Cancer Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Medicine in Prostate Cancer Key Manufacturers in 2014
Table United States Production of Medicine in Prostate Cancer by Regions 2010-2015 (Dose)
Table United States Production Market Share of Medicine in Prostate Cancer by Regions 2010-2015
Figure United States Production Market Share of Medicine in Prostate Cancer by Regions in 2014
Figure United States Production Market Share of Medicine in Prostate Cancer by Regions in 2015
Table United States Production of Medicine in Prostate Cancer by Types in 2010-2015 (Dose)
Table United States Production Market Share of Medicine in Prostate Cancer by Type in 2010-2015
Figure United States Production Market Share of Medicine in Prostate Cancer by Type in 2014
Figure United States Production Market Share of Medicine in Prostate Cancer by Type in 2015
Table United States Sales of Medicine in Prostate Cancer by Applications 2010-2015 (Dose)
Table United States Production Market Share of Medicine in Prostate Cancer by Applications 2010-2015
Figure United States Production Market Share of Medicine in Prostate Cancer by Applications in 2014
Figure United States Production Market Share of Medicine in Prostate Cancer by Applications in 2015
Table Price Comparison of United States Medicine in Prostate Cancer Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Medicine in Prostate Cancer 2010-2015
Table United States Consumption Volume of Medicine in Prostate Cancer by Regions 2010-2015 (Dose)
Table United States Consumption Volume Market Share of Medicine in Prostate Cancer by Regions 2010-2015 (%)
Figure United States Consumption Volume Market Share of Medicine in Prostate Cancer by Regions in 2014
Figure United States Consumption Volume Market Share of Medicine in Prostate Cancer by Regions in 2015
Table United States Consumption Value of Medicine in Prostate Cancer by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Medicine in Prostate Cancer by Regions 2010-2015
Figure United States Consumption Value Market Share of Medicine in Prostate Cancer by Regions in 2014
Figure United States Consumption Value Market Share of Medicine in Prostate Cancer by Regions in 2015
Table Consumption Price of Medicine in Prostate Cancer by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Medicine in Prostate Cancer 2010-2015 (Dose)
Table United States Capacity Market Share of Major Medicine in Prostate Cancer Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Medicine in Prostate Cancer 2010-2015 (Dose)
Table United States Production Market Share of Major Medicine in Prostate Cancer Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Medicine in Prostate Cancer 2010-2015 (Dose)
Table United States Sales Market Share of Major Medicine in Prostate Cancer Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Medicine in Prostate Cancer 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Medicine in Prostate Cancer Manufacturers 2010-2015
Figure United States Capacity (Dose), Production (Dose) and Growth Rate of Medicine in Prostate Cancer 2010-2015
Figure United States Capacity Utilization Rate of Medicine in Prostate Cancer 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Medicine in Prostate Cancer 2010-2015
Figure United States Production Market Share of Major Medicine in Prostate Cancer Manufacturers in 2014
Figure United States Production Market Share of Major Medicine in Prostate Cancer Manufacturers in 2015
Figure United States Sales Market Share of Major Medicine in Prostate Cancer Manufacturers in 2014
Figure United States Sales Market Share of Major Medicine in Prostate Cancer Manufacturers in 2015
Figure United States Sales (Dose) and Growth Rate of Medicine in Prostate Cancer 2010-2015
Table United States Supply, Consumption and Gap of Medicine in Prostate Cancer 2010-2015 (Dose)
Table United States Import, Export and Consumption of Medicine in Prostate Cancer 2010-2015 (Dose)
Table Price of United States Medicine in Prostate Cancer Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Medicine in Prostate Cancer Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Medicine in Prostate Cancer 2010-2015 (M USD)
Table United States Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Medicine in Prostate Cancer 2010-2015
Table Abbott Diagnostics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Abbott Diagnostics
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Abbott Diagnostics 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Abbott Diagnostics 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Abbott Diagnostics 2010-2015
Table Abbott Diagnostics Medicine in Prostate Cancer SWOT Analysis
Table Active Biotech Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Active Biotech
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Active Biotech 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Active Biotech 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Active Biotech 2010-2015
Table Active Biotech Medicine in Prostate Cancer SWOT Analysis
Table Advantagene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Advantagene
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Advantagene 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Advantagene 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Advantagene 2010-2015
Table Advantagene Medicine in Prostate Cancer SWOT Analysis
Table AEterna Zentaris Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of AEterna Zentaris
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AEterna Zentaris 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of AEterna Zentaris 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of AEterna Zentaris 2010-2015
Table AEterna Zentaris Medicine in Prostate Cancer SWOT Analysis
Table Alchemia Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Alchemia
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alchemia 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Alchemia 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Alchemia 2010-2015
Table Alchemia Medicine in Prostate Cancer SWOT Analysis
Table Alethia Biotherapeutics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Alethia Biotherapeutics
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alethia Biotherapeutics 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Alethia Biotherapeutics 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Alethia Biotherapeutics 2010-2015
Table Alethia Biotherapeutics Medicine in Prostate Cancer SWOT Analysis
Table Generex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Generex
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Generex 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Generex 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Generex 2010-2015
Table Generex Medicine in Prostate Cancer SWOT Analysis
Table Alseres Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Alseres
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alseres 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Alseres 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Alseres 2010-2015
Table Alseres Medicine in Prostate Cancer SWOT Analysis
Table Bayer Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Bayer
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bayer 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Bayer 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Bayer 2010-2015
Table Bayer Medicine in Prostate Cancer SWOT Analysis
Table Altor BioScience Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Altor BioScience
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Altor BioScience 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Altor BioScience 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Altor BioScience 2010-2015
Table Altor BioScience Medicine in Prostate Cancer SWOT Analysis
Table Bavarian Nordic Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Bavarian Nordic
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bavarian Nordic 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Bavarian Nordic 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Bavarian Nordic 2010-2015
Table Bavarian Nordic Medicine in Prostate Cancer SWOT Analysis
Table Amgen Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Amgen
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Amgen 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Amgen 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Amgen 2010-2015
Table Amgen Medicine in Prostate Cancer SWOT Analysis
Table Inovio Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Inovio
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Inovio 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Inovio 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Inovio 2010-2015
Table Inovio Medicine in Prostate Cancer SWOT Analysis
Table Anavex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Anavex
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Anavex 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Anavex 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Anavex 2010-2015
Table Anavex Medicine in Prostate Cancer SWOT Analysis
Table Antisense Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Antisense Pharma
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Antisense Pharma 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Antisense Pharma 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Antisense Pharma 2010-2015
Table Antisense Pharma Medicine in Prostate Cancer SWOT Analysis
Table Aphios Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Aphios
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Aphios 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Aphios 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Aphios 2010-2015
Table Aphios Medicine in Prostate Cancer SWOT Analysis
Table Apotex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Apotex
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Apotex 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Apotex 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Apotex 2010-2015
Table Apotex Medicine in Prostate Cancer SWOT Analysis
Table Aprea Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Aprea
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Aprea 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Aprea 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Aprea 2010-2015
Table Aprea Medicine in Prostate Cancer SWOT Analysis
Table MediGene Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of MediGene
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of MediGene 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of MediGene 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of MediGene 2010-2015
Table MediGene Medicine in Prostate Cancer SWOT Analysis
Table Array BioPharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Array BioPharma
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Array BioPharma 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Array BioPharma 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Array BioPharma 2010-2015
Table Array BioPharma Medicine in Prostate Cancer SWOT Analysis
Table Bioenvision Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Bioenvision
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bioenvision 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Bioenvision 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Bioenvision 2010-2015
Table Bioenvision Medicine in Prostate Cancer SWOT Analysis
Table Astellas Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Astellas
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astellas 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Astellas 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Astellas 2010-2015
Table Astellas Medicine in Prostate Cancer SWOT Analysis
Table Astex Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Medicine in Prostate Cancer Picture and Specifications of Astex
Table Medicine in Prostate Cancer Capacity (Dose), Production (Dose), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astex 2010-2015
Figure Medicine in Prostate Cancer Capacity (Dose), Production (Dose) and Growth Rate of Astex 2010-2015
Figure Medicine in Prostate Cancer Production (Dose) and United States Market Share of Astex 2010-2015
Table Astex Medicine in Prostate Cancer SWOT Analysis
Table Medicine in Prostate Cancer Price by Regions 2010-2015
Table Medicine in Prostate Cancer Price by Product Types 2010-2015
Table Medicine in Prostate Cancer Price by Companies 2010-2015
Table Medicine in Prostate Cancer Gross Margin by Companies 2010-2015
Table Price Comparison of Medicine in Prostate Cancer by Regions 2010-2015 (USD/Dose)
Table Price of Different Medicine in Prostate Cancer Product Types (USD/Dose)
Table Market Share of Different Medicine in Prostate Cancer Price Level
Table Gross Margin of Different Medicine in Prostate Cancer Applications
Table Marketing Channels Status of Medicine in Prostate Cancer
Table Traders or Distributors of Medicine in Prostate Cancer with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Medicine in Prostate Cancer (USD/Dose) in 2015
Table United States Import, Export, and Trade of Medicine in Prostate Cancer (Dose)
Figure United States Capacity (Dose), Production (Dose) and Growth Rate of Medicine in Prostate Cancer 2016-2021
Figure United States Capacity Utilization Rate of Medicine in Prostate Cancer 2016-2021
Table United States Medicine in Prostate Cancer Production by Type 2016-2021 (Dose)
Table United States Medicine in Prostate Cancer Production Market Share by Type 2016-2021
Figure United States Production Market Share of Medicine in Prostate Cancer by Type in 2021
Figure United States Sales (Dose) and Growth Rate of Medicine in Prostate Cancer 2016-2021
Figure United States Sales Revenue (Million USD) and Growth Rate of Medicine in Prostate Cancer 2016-2021
Figure United States Sales of Medicine in Prostate Cancer by Applications 2016-2021 (Dose)
Table United States Production Market Share of Medicine in Prostate Cancer by Applications 2016-2021
Figure United States Production Market Share of Medicine in Prostate Cancer by Applications in 2021
Table United States Production, Import, Export and Consumption of Medicine in Prostate Cancer 2016-2021 (Dose)
Table United States Production (Dose), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Medicine in Prostate Cancer 2016-2021
Table Major Raw Materials Suppliers of Medicine in Prostate Cancer with Contact Information
Table Manufacturing Equipment Suppliers of Medicine in Prostate Cancer with Contact Information
Table Major Players of Medicine in Prostate Cancer with Contact Information
Table Key Consumers of Medicine in Prostate Cancer with Contact Information
Table Supply Chain Relationship Analysis of M

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer: Analytical Tool

Prostate Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

Epiomic Epidemiology Series: Prostate Cancer Forecast in 18 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • September 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Prostate Cancer in 18 Major Markets Prostate cancer is one of the most common cancers in men. The prostate, found only in men, is the ...

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

Prostate cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Prostate cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the UK

  • November 2016
    12 pages
  • Cancer  

  • United Kingdom  

    Europe  

View report >

Colorectal Cancer Statistics in the Netherlands

  • November 2016
    10 pages
  • Colorectal Canc...  

  • Netherlands  

View report >

Obesity Statistics and Cancer Statistics in the US

  • November 2016
    7 pages
  • Obesity  

    Cancer  

    Oncology  

  • United States  

    North America  

View report >

Related Market Segments :

Prostate Cancer

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.